BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 25892229)

  • 1. SF3B1 association with chromatin determines splicing outcomes.
    Kfir N; Lev-Maor G; Glaich O; Alajem A; Datta A; Sze SK; Meshorer E; Ast G
    Cell Rep; 2015 Apr; 11(4):618-29. PubMed ID: 25892229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin-dependent kinase 1 (CDK1) and CDK2 have opposing roles in regulating interactions of splicing factor 3B1 with chromatin.
    Murthy T; Bluemn T; Gupta AK; Reimer M; Rao S; Pillai MM; Minella AC
    J Biol Chem; 2018 Jun; 293(26):10220-10234. PubMed ID: 29764937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SF3B1/Hsh155 HEAT motif mutations affect interaction with the spliceosomal ATPase Prp5, resulting in altered branch site selectivity in pre-mRNA splicing.
    Tang Q; Rodriguez-Santiago S; Wang J; Pu J; Yuste A; Gupta V; Moldón A; Xu YZ; Query CC
    Genes Dev; 2016 Dec; 30(24):2710-2723. PubMed ID: 28087715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-Associated SF3B1 Hotspot Mutations Induce Cryptic 3' Splice Site Selection through Use of a Different Branch Point.
    Darman RB; Seiler M; Agrawal AA; Lim KH; Peng S; Aird D; Bailey SL; Bhavsar EB; Chan B; Colla S; Corson L; Feala J; Fekkes P; Ichikawa K; Keaney GF; Lee L; Kumar P; Kunii K; MacKenzie C; Matijevic M; Mizui Y; Myint K; Park ES; Puyang X; Selvaraj A; Thomas MP; Tsai J; Wang JY; Warmuth M; Yang H; Zhu P; Garcia-Manero G; Furman RR; Yu L; Smith PG; Buonamici S
    Cell Rep; 2015 Nov; 13(5):1033-45. PubMed ID: 26565915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.
    Dolatshad H; Pellagatti A; Fernandez-Mercado M; Yip BH; Malcovati L; Attwood M; Przychodzen B; Sahgal N; Kanapin AA; Lockstone H; Scifo L; Vandenberghe P; Papaemmanuil E; Smith CW; Campbell PJ; Ogawa S; Maciejewski JP; Cazzola M; Savage KI; Boultwood J
    Leukemia; 2015 May; 29(5):1092-103. PubMed ID: 25428262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The SF3b155 N-terminal domain is a scaffold important for splicing.
    Cass DM; Berglund JA
    Biochemistry; 2006 Aug; 45(33):10092-101. PubMed ID: 16906767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into human pre-mRNA splicing of human ultra-short introns: potential unusual mechanism identifies G-rich introns.
    Sasaki-Haraguchi N; Shimada MK; Taniguchi I; Ohno M; Mayeda A
    Biochem Biophys Res Commun; 2012 Jun; 423(2):289-94. PubMed ID: 22640740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo.
    Martinez E; Palhan VB; Tjernberg A; Lymar ES; Gamper AM; Kundu TK; Chait BT; Roeder RG
    Mol Cell Biol; 2001 Oct; 21(20):6782-95. PubMed ID: 11564863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of cancer-associated mutations in Hsh155/SF3b1 HEAT repeats 9-12 on pre-mRNA splicing in Saccharomyces cerevisiae.
    Kaur H; Groubert B; Paulson JC; McMillan S; Hoskins AA
    PLoS One; 2020; 15(4):e0229315. PubMed ID: 32320410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SPF45/RBM17-dependent, but not U2AF-dependent, splicing in a distinct subset of human short introns.
    Fukumura K; Yoshimoto R; Sperotto L; Kang HS; Hirose T; Inoue K; Sattler M; Mayeda A
    Nat Commun; 2021 Aug; 12(1):4910. PubMed ID: 34389706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated mutations in SF3B1 disrupt the interaction between SF3B1 and DDX42.
    Zhao B; Li Z; Qian R; Liu G; Fan M; Liang Z; Hu X; Wan Y
    J Biochem; 2022 Jul; 172(2):117-126. PubMed ID: 35652295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pre-mRNA splicing and transcription factor Tat-SF1 is a functional partner of the spliceosome SF3b1 subunit via a U2AF homology motif interface.
    Loerch S; Leach JR; Horner SW; Maji D; Jenkins JL; Pulvino MJ; Kielkopf CL
    J Biol Chem; 2019 Feb; 294(8):2892-2902. PubMed ID: 30567737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.
    Wu G; Fan L; Edmonson MN; Shaw T; Boggs K; Easton J; Rusch MC; Webb TR; Zhang J; Potter PM
    RNA; 2018 Aug; 24(8):1056-1066. PubMed ID: 29844105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SF3b1 mutations associated with myelodysplastic syndromes alter the fidelity of branchsite selection in yeast.
    Carrocci TJ; Zoerner DM; Paulson JC; Hoskins AA
    Nucleic Acids Res; 2017 May; 45(8):4837-4852. PubMed ID: 28062854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages.
    Effenberger KA; Urabe VK; Prichard BE; Ghosh AK; Jurica MS
    RNA; 2016 Mar; 22(3):350-9. PubMed ID: 26742993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complex assembly mechanism and an RNA-binding mode of the human p14-SF3b155 spliceosomal protein complex identified by NMR solution structure and functional analyses.
    Kuwasako K; Dohmae N; Inoue M; Shirouzu M; Taguchi S; Güntert P; Séraphin B; Muto Y; Yokoyama S
    Proteins; 2008 Jun; 71(4):1617-36. PubMed ID: 18076038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The protein kinase DYRK1A phosphorylates the splicing factor SF3b1/SAP155 at Thr434, a novel in vivo phosphorylation site.
    de Graaf K; Czajkowska H; Rottmann S; Packman LC; Lilischkis R; Lüscher B; Becker W
    BMC Biochem; 2006 Mar; 7():7. PubMed ID: 16512921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U2AF
    Tari M; Manceau V; de Matha Salone J; Kobayashi A; Pastré D; Maucuer A
    EMBO Rep; 2019 Aug; 20(8):e47604. PubMed ID: 31271494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular architecture of the human 17S U2 snRNP.
    Zhang Z; Will CL; Bertram K; Dybkov O; Hartmuth K; Agafonov DE; Hofele R; Urlaub H; Kastner B; Lührmann R; Stark H
    Nature; 2020 Jul; 583(7815):310-313. PubMed ID: 32494006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of the SETBP1 gene and splicing pathway genes SF3B1, U2AF1, and SRSF2 in childhood acute myeloid leukemia.
    Choi HW; Kim HR; Baek HJ; Kook H; Cho D; Shin JH; Suh SP; Ryang DW; Shin MG
    Ann Lab Med; 2015 Jan; 35(1):118-22. PubMed ID: 25553291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.